RevCycle Intelligence March 16, 2021
Hannah Nelson

Lack of clinical data analysis in the development of CMS’ metastatic risk adjuster may lead to skewed bundle payments for oncological care.

Incorporating clinical data into risk stratification could improve the accuracy of CMS bundled payment models like the Oncology Care Model (OCM), according to a new Avalere analysis.

The OCM is a bundled payment model that evaluates the total cost of care for episodes initiated by chemotherapy treatments within six-month performance periods (PP). At the end of each period, CMS measures practice performance by comparing total expenditures to a benchmark price predicted by factors like tumor type, comorbidities, member demographics, and utilization of certain services.

Participating practices that stay within the benchmark price earn a performance-based payment (PBP) and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Bundled Payments, CMS, Govt Agencies, Insurance, Payment Models, Provider, Survey / Study, Trends, Value Based
Mandatory Medicare Bundled Payment and the Future of Hospital Reimbursement
Medicare’s New Mandatory Bundled-Payment Program — Are We Ready for TEAM?
What you need to know about CMS' TEAM payment model
CMS releases participant list for mandatory Transforming Episode Accountability Model
Integrating Maternity Care Through Bundled Payments In The Netherlands: Early Results And Policy Lessons

Share This Article